Share of Clicks for top 10 US Pharma & Biotech Infectious Diseases brands
Here are the Top 10 competitors in the industry by Share of Clicks for the last month.
| Domain | Share of clicks |
|---|---|
| paxlovid.com | 21.25 |
| mavyret.com | 10.64 |
| uqora.com | 8.81 |
| treatmyuti.com | 8.16 |
| admired.com | 5.42 |
| cabenuva.com | 5.42 |
| prevnar20.com | 3.4 |
| goodrx.com | 3.18 |
| epclusa.com | 3.08 |
| dovato.com | 2.77 |
| others | 27.87 |
- paxlovid.com - 21.25%
- mavyret.com - 10.64%
- uqora.com - 8.81%
- treatmyuti.com - 8.16%
- admired.com - 5.42%
- cabenuva.com - 5.42%
- prevnar20.com - 3.4%
- goodrx.com - 3.18%
- epclusa.com - 3.08%
- dovato.com - 2.77%
- others - 27.87%
Copyright © Adthena. All rights reserved.
In the PPC landscape, paxlovid.com leads with 21.25% click share, while ‘others’ collectively hold 27.87%, showcasing diverse competition.
Share of Spend for the top 10 US Pharma & Biotech Infectious Diseases brands
Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.
| Date | cabenuva.com | mavyret.com | uqora.com | dovato.com | paxlovid.com | admired.com | prevnar20.com | epclusa.com | treatmyuti.com | apretude.com |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/07/01 | 13.96% | 11.86% | 3.54% | 11.7% | 0.43% | 0% | 1.85% | 5.82% | 0% | 2.66% |
| 2026/07/02 | 13.53% | 14.49% | 0% | 10.78% | 2.14% | 0% | 4.87% | 8.51% | 0% | 6.1% |
| 2026/07/03 | 16.3% | 13.11% | 0% | 8.57% | 6.93% | 0% | 6.82% | 5.82% | 0% | 2.06% |
| 2026/07/04 | 14.83% | 9.68% | 5.47% | 11.34% | 6.85% | 0% | 5.63% | 6.06% | 0% | 3.02% |
| 2026/07/05 | 14.6% | 17.7% | 0% | 9.66% | 6.02% | 0% | 4.62% | 5.02% | 0% | 1.79% |
| 2026/07/06 | 13.75% | 13.05% | 0% | 11.5% | 6.47% | 0% | 5.42% | 5.84% | 0% | 4.11% |
| 2026/07/07 | 10.76% | 13.55% | 17.88% | 8.22% | 6.05% | 0% | 3.94% | 6.47% | 0% | 2.06% |
| 2026/07/08 | 11.18% | 13.23% | 6.31% | 7.74% | 5.72% | 4.57% | 3.79% | 7.2% | 1.11% | 2.73% |
| 2026/07/09 | 11.18% | 4.65% | 6.62% | 6.7% | 6.29% | 5.62% | 4% | 3.46% | 8.6% | 4.07% |
| 2026/07/10 | 13.76% | 8.38% | 5.95% | 8.87% | 7.2% | 5.47% | 3.53% | 7.14% | 4.64% | 1.35% |
| 2026/07/11 | 15.26% | 6.11% | 7.21% | 10.11% | 6.03% | 5.67% | 4.84% | 3.72% | 4.23% | 3.61% |
| 2026/07/12 | 12.28% | 17.01% | 0% | 10.82% | 8.14% | 0% | 5.91% | 8.34% | 0% | 2.39% |
| 2026/07/13 | 11.7% | 18.21% | 2.16% | 10.3% | 7.36% | 0% | 5.47% | 4.87% | 0% | 2.29% |
| 2026/07/14 | 13.85% | 15.83% | 0% | 11.01% | 8.09% | 0% | 6.43% | 6.3% | 0% | 5.73% |
| 2026/07/15 | 6.02% | 4.84% | 9.71% | 5.94% | 4.74% | 13.93% | 2.51% | 2.33% | 15.17% | 0.6% |
| 2026/07/16 | 9.13% | 9.23% | 6.02% | 5.46% | 6.39% | 7.8% | 3.69% | 2.73% | 11.05% | 1.14% |
| 2026/07/17 | 13.45% | 12.3% | 0% | 12.05% | 8.48% | 0% | 5.3% | 6.11% | 0% | 2.09% |
| 2026/07/18 | 18.22% | 11.99% | 3.44% | 9.66% | 8.32% | 0% | 6.08% | 5.02% | 0% | 3.47% |
| 2026/07/19 | 12.36% | 9.81% | 9.22% | 7.33% | 6.26% | 8.28% | 2.75% | 2.77% | 2.83% | 3.91% |
| 2026/07/20 | 10.82% | 6.2% | 18.81% | 8.23% | 5.71% | 12.53% | 3.83% | 4.52% | 6.36% | 0.59% |
| 2026/07/21 | 13.85% | 15.83% | 0% | 11.01% | 8.09% | 0% | 6.43% | 6.3% | 0% | 5.73% |
| 2026/07/22 | 13.39% | 10.4% | 2.72% | 10.83% | 6.32% | 8.28% | 3.19% | 3.32% | 8.24% | 2.64% |
| 2026/07/23 | 18.76% | 10.45% | 3.23% | 7.82% | 6.96% | 3.11% | 4.96% | 4.88% | 0% | 2.94% |
| 2026/07/24 | 13.6% | 6.51% | 6.74% | 7.9% | 5.51% | 1.49% | 3.07% | 5.17% | 1.06% | 5.52% |
| 2026/07/25 | 13.81% | 7.19% | 6.47% | 5.61% | 4.77% | 4.55% | 2.44% | 2.97% | 11.55% | 2.89% |
| 2026/07/26 | 14.06% | 5.6% | 11.06% | 5.12% | 4.53% | 8.46% | 3.64% | 2.73% | 5.29% | 2.63% |
| 2026/07/27 | 10.24% | 7.14% | 10.05% | 7.04% | 4.48% | 5.44% | 2.76% | 3.36% | 8.42% | 3.21% |
| 2026/07/28 | 6.68% | 6.54% | 3.51% | 8.43% | 5.08% | 3.47% | 2.44% | 2.87% | 10.18% | 5.14% |
| 2026/07/29 | 8.81% | 7.88% | 6.97% | 9.25% | 4.87% | 5.85% | 4.49% | 2.78% | 12.06% | 6.5% |
| 2026/07/30 | 10.44% | 6.44% | 3% | 5.92% | 5.54% | 4.63% | 3.66% | 3.14% | 5.52% | 4.79% |
| 2026/07/31 | 15.07% | 10.82% | 9.74% | 6.49% | 5.13% | 5.01% | 4.81% | 4.75% | 4.73% | 4.11% |
- cabenuva.com
- mavyret.com
- uqora.com
- dovato.com
- paxlovid.com
- admired.com
- prevnar20.com
- epclusa.com
- treatmyuti.com
- apretude.com
Copyright © Adthena. All rights reserved.
Cabenuva.com led July with fluctuating trends, peaking mid-month. Mavyret.com showed a strong start, dipping later. Uqora.com spiked early, stabilizing. Dovato.com maintained steady performance. Paxlovid.com and others had varied patterns, ending July with mixed results.
Competitor Count for US Pharma & Biotech Infectious Diseases
Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.
| Date | Competitor Count |
|---|---|
| 2026/07/01 | 69 |
| 2026/07/02 | 64 |
| 2026/07/03 | 64 |
| 2026/07/04 | 64 |
| 2026/07/05 | 65 |
| 2026/07/06 | 67 |
| 2026/07/07 | 73 |
| 2026/07/08 | 72 |
| 2026/07/09 | 71 |
| 2026/07/10 | 68 |
| 2026/07/11 | 69 |
| 2026/07/12 | 70 |
| 2026/07/13 | 73 |
| 2026/07/14 | 68 |
| 2026/07/15 | 70 |
| 2026/07/16 | 69 |
| 2026/07/17 | 65 |
| 2026/07/18 | 69 |
| 2026/07/19 | 73 |
| 2026/07/20 | 70 |
| 2026/07/21 | 68 |
| 2026/07/22 | 74 |
| 2026/07/23 | 76 |
| 2026/07/24 | 77 |
| 2026/07/25 | 77 |
| 2026/07/26 | 80 |
| 2026/07/27 | 75 |
| 2026/07/28 | 75 |
| 2026/07/29 | 76 |
| 2026/07/30 | 74 |
| 2026/07/31 | 73 |
Copyright © Adthena. All rights reserved.
July began with 69 advertisers, fluctuating slightly mid-month. A notable rise occurred from July 22, peaking at 80 on July 26. The month concluded with 73 advertisers.
